EUVIMEDEUVIMED entdecken
Crossref

A comparative retrospective study on syphilis serology in HIV-positive and negative individuals before and after therapy

Amira Rahmatika, Afif Hidayati, Cita Prakoeswa, Muhammad Listiawan, Rahmadewi Rahmadewi, Damayanti Damayanti, Budi Utomo, Dwi Murtiastutik, Astindari Astindari, Maylita Sari, Septiana Widyantari, Regitta Agusni

Journal of Advanced Biotechnology and Experimental Therapeutics · 2024 · 7 (2) · 442

DOI: 10.5455/jabet.2024.d38 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Biotechnology and Experimental Therapeutics, 2024. Verfasst von Amira Rahmatika und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Syphilis serological tests are crucial for diagnosing and evaluating syphilis therapy. Human immunodeficiency virus (HIV) infection can alter syphilis serologies, making manifestations more atypical and increasing complications. This study aims to compare treponemal and nontreponemal titers before and after therapy between HIV-positive and negative patients. From January 2018 to December 2021, we retrospectively evaluated patients diagnosed with early and latent syphilis using quantitative nontreponemal and treponemal serologies (VDRL and TPHA) and categorized them as HIV-positive or negative. Baseline and post-therapy (1 month and last follow-up within 2 years) VDRL and TPHA titers were recorded. Twenty-nine HIV-negative and 28 HIV-positive patients met the inclusion criteria. Baseline VDRL and TPHA titers differed significantly between both groups, particularly in early syphilis, with the median baseline VDRL titer higher in the HIV-positive group. At 1-month and the last follow-up after therapy, VDRL titers continued to differ significantly, underscoring the impact of HIV coinfection on treatment response. Notably, TPHA titers exhibited significant differences between the two groups only at the last follow-up in overall syphilis. The HIV-positive group showed a higher percentage of patients failing to achieve a serological cure (60.7% vs. 58.6%). HIV coinfection in syphilis patients affects both nontreponemal and treponemal titers and elevates the treatment failure risk. This study highlights the importance of periodic syphilis serology tests in coinfected individuals to ensure treatment effectiveness, detect reinfection promptly, and prevent complications.

Zitieren

APA

Rahmatika, A., Hidayati, A., Prakoeswa, C., Listiawan, M., Rahmadewi, R., Damayanti, D., Utomo, B., Murtiastutik, D., Astindari, A., Sari, M., Widyantari, S., & Agusni, R. (2024). A comparative retrospective study on syphilis serology in HIV-positive and negative individuals before and after therapy. Journal of Advanced Biotechnology and Experimental Therapeutics, 7(2), 442. https://doi.org/10.5455/jabet.2024.d38

Vancouver

Rahmatika A, Hidayati A, Prakoeswa C, Listiawan M, Rahmadewi R, Damayanti D, et al. A comparative retrospective study on syphilis serology in HIV-positive and negative individuals before and after therapy. Journal of Advanced Biotechnology and Experimental Therapeutics. 2024;7(2):442. doi:10.5455/jabet.2024.d38

BibTeX
@article{Rahmatika2024,
  author = {Rahmatika, Amira and Hidayati, Afif and Prakoeswa, Cita and Listiawan, Muhammad and Rahmadewi, Rahmadewi and Damayanti, Damayanti and Utomo, Budi and Murtiastutik, Dwi and Astindari, Astindari and Sari, Maylita and Widyantari, Septiana and Agusni, Regitta},
  title = {A comparative retrospective study on syphilis serology in HIV-positive and negative individuals before and after therapy},
  journal = {Journal of Advanced Biotechnology and Experimental Therapeutics},
  year = {2024},
  volume = {7},
  number = {2},
  pages = {442},
  doi = {10.5455/jabet.2024.d38}
}
Kostenlos starten →